A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function
Public ClinicalTrials.gov record NCT04486482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory, Open Label, Clinical Study to Evaluate the Physiologic Effects of KB109 in Adult Patients With Mild-to-Moderate COVID-19 on Gut Microbiota Structure and Function in the Outpatient Setting
Study identification
- NCT ID
- NCT04486482
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Kaleido Biosciences
- Industry
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- KB109 + Self Supportive Care (SSC) Other
- Self Supportive Care (SSC) Alone Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 11, 2021
- Primary completion
- Mar 29, 2021
- Completion
- Mar 29, 2021
- Last update posted
- Aug 12, 2021
2021
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cullman Clinical Trials | Cullman | Alabama | 35055 | — |
| American Institute of Research | Los Angeles | California | 90017 | — |
| Rancho Cucamonga Clinical Research | Rancho Cucamonga | California | 91730 | — |
| Next Phase Research Alliance | Boca Raton | Florida | 33166 | — |
| Advanced Pharma CR, LLC | Miami | Florida | 33147 | — |
| Hope Clinical Trials | Miami | Florida | 33165 | — |
| Kendall South Medical Center, Inc. | Miami | Florida | 33185 | — |
| Quad Clinical Research | Chicago | Illinois | 60605 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Inquest Research | Baytown | Texas | 77521 | — |
| Olympus Family Medicine | Salt Lake City | Utah | 84117 | — |
| South Ogden Family Medicine Center | South Ogden | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04486482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04486482 live on ClinicalTrials.gov.